Rodríguez Celestino, Areces Débora, García Trinidad, Cueli Marisol, González-Castro Paloma
Universidad de Oviedo, Spain.
Int J Clin Health Psychol. 2018 Sep-Dec;18(3):254-263. doi: 10.1016/j.ijchp.2018.06.003. Epub 2018 Aug 6.
Continuous Performance Tests (CPTs) have demonstrated validity when differentiating children with ADHD from healthy controls. However, these CPTs have limitations such as low ecological validity. New CPTs based on the use of Virtual Reality (VR) have appeared as supposedly improved methods for assessing ADHD. This study aims to compare the discriminant value of attentional variables produced by a VR CPT (Aula Nesplora) with that of variables from a traditional CPT (Test of Variables of Attention; TOVA) for identifying ADHD A total of 338 children aged between 6 and 16 years old ( = 10.84, = 3.01) participated in the study: 31.95% correspond to the inattentive presentation, 15.38% to the impulsive-hyperactive presentation, 22.78% to the combined presentation, and the remaining 29.88% correspond to children without ADHD. Results indicated that Aula Nesplora predicts ADHD presentations better than TOVA. It also differentiates better between ADHD and non-ADHD students. These findings show the potential advantages of using virtual reality in ADHD assessment, as it facilitates the diagnosis of ADHD and the differentiation of its presentations in a realistic environment.
连续性能测试(CPTs)在区分患有注意力缺陷多动障碍(ADHD)的儿童与健康对照组时已证明其有效性。然而,这些CPTs存在局限性,如生态效度较低。基于虚拟现实(VR)使用的新型CPTs已作为评估ADHD的改进方法出现。本研究旨在比较虚拟现实CPT(奥拉·内斯普洛拉)产生的注意力变量与传统CPT(注意力变量测试;TOVA)的变量在识别ADHD方面的判别价值。共有338名6至16岁的儿童(平均年龄 = 10.84,标准差 = 3.01)参与了该研究:31.95%为注意力不集中型,15.38%为冲动多动型,22.78%为混合型,其余29.88%为无ADHD的儿童。结果表明,奥拉·内斯普洛拉比TOVA能更好地预测ADHD类型。它在ADHD学生和非ADHD学生之间的区分也更好。这些发现显示了在ADHD评估中使用虚拟现实的潜在优势,因为它有助于在现实环境中对ADHD进行诊断及其类型的区分。
Int J Clin Health Psychol. 2018
J Dev Behav Pediatr. 2009-2
Front Psychiatry. 2024-12-18
IEEE J Transl Eng Health Med. 2024
Front Digit Health. 2024-10-8
Neurosci Biobehav Rev. 2024-12
Sci Rep. 2023-8-22
World J Psychiatry. 2021-11-19
Int J Environ Res Public Health. 2021-9-6
Int J Clin Health Psychol. 2017
Int J Clin Health Psychol. 2016
Atten Defic Hyperact Disord. 2017-12
Front Psychol. 2016-9-21
J Atten Disord. 2015-3-19
J Health Econ. 2014-9